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Food safety begins on the farm with management practices that contribute to an 
abundant, safe, and affordable food supply. To attain this goal antimicrobials have 
been used in all stages of food animal production in the United States and elsewhere 
around the world at one time or another. Among food–production animals 
antimicrobials are used for growth promotion, disease prophylaxis or disease 
treatment, and are generally administered to the entire flock or herd. Over many 
decades bacteria have become resistant to multiple antimicrobial classes in a 
cumulative manner. Bacteria exhibit a number of well characterized mechanisms of 
resistance to antimicrobials that include: 1) modification of the antimicrobial; 2) 
alteration of the drug target; 3) decreased access of drug to target; and 4) 
implementation of an alternative metabolic pathway not affected by the drug. The 
mechanisms of resistance are complex and depend on the type of bacterium 
involved (e.g. Gram–positive or Gram–negative) and the class of drug. Some 
bacterial species have accumulated resistance to nearly all antimicrobial classes due 
to a combination of intrinsic and acquired processes. This has and will continue to 
lead to clinical failures of antimicrobial treatment in both human and animal 
medicine. 
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INTRODUCTION 
 
Bacteria reside in complex ecological habitats and 
many commercially available antibiotics were first 
isolated from soil dwelling, Actinobacteria. Shortly after 
antibacterial agents were discovered, it was determined 
that some microorganisms were resistant to their effects 
(Furuya and Lowy, 2006). Often this was to provide 
immunity to a strain from its own antibiotic. 
Alternatively, susceptible bacteria in the same ecological 
niche acquired various mechanisms to protect themselves 
from exogenously produced antibiotics. Many self–
protection genes were originally present as operons on the 
bacterial chromosome (D'Costa et al., 2006). The vast 
array of bacteria in the environment and within animals 
and humans provides an infinite reservoir of antimicrobial 
resistance genes (Sommer et al., 2009; Sommer et al., 
2010; Forsberg, et al., 2012). There are different origins to 
the many types of resistance genes in the environment that 
are now referred to as the antibiotic resistome (D'Costa et 
al., 2006; Fajardo et al., 2008; Davies and Davies, 2010). 
Analysis of the antibiotic resistome has predicted the 
possibility of over 400 putative antibiotic resistance genes 
(Bailey et al., 2010; Davies and Davies, 2010; Sommer et 
al., 2010). 
Although understanding the biochemical mechanisms 
of antimicrobial resistance are important, of equal 
importance is elucidating the ability of these genetic traits 
to disseminate globally. If a bacterium acquires resistance 
genes, but resides in a dead end niche where it does not 
come in contact with a transmissible vector, then it is of 
little consequence to human or animal populations. 
However, the extensive use of antimicrobials in food 
animal production has produced a reservoir for multiple 
drug resistant (MDR) commensals and pathogens in the 
gastrointestinal tracts of food animals (Alexander et al., 
2011; Sparo et al., 2012). Many of the antimicrobial 
resistant bacteria do not cause disease in the food animals, 
but are pathogenic to humans and may be transmitted to 
humans via a fecal to oral route. Many epidemiological 
studies have been done to demonstrate the progression of 
pathogens through the food chain to humans (Bywater 
2005; Hauser et al., 2010; Depoorter et al., 2012; Gomes-
Neves et al., 2012; Merchant et al., 2012). Antimicrobial 
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resistance gene transfer has been experimentally 
demonstrated in the gastrointestinal tracts of poultry (Poole 
et al., 2006), lesser mealworm beetles and larvae that infest 
poultry houses (Crippen and Poole 2009; Poole and 
Crippen, 2009). This was shown by introducing both 
recipient and donor strains to the target host. Therefore, in 
order to mitigate dissemination, all reservoirs need to be 
identified and controlled if not eliminated. 
 
Mechanisms of dissemination: Mobile genetic elements 
have provided a rapid method of dissemination of 
antimicrobial resistance genes at the molecular level. The 
ease by which multiple drug resistance has emerged 
exemplifies the genetic fluidity that exists within microbial 
communities and represents an important mechanism that 
drives bacterial evolution. Many antimicrobial resistance 
genes that were chromosomal in origin have been 
translocated to mobile genetic elements such as broad–host 
range plasmids, transposons, integrons and phage, with 
plasmids playing the most significant role in horizontal 
dissemination (Smillie et al., 2010).  
Plasmids are covalently closed circular pieces of DNA 
that replicate independently from the bacterial chromosome 
and may be transferred across genus and species boundaries 
(Carattoli, 2009). They vary in size from a single kilobase 
to 250 kilobases or more. It is estimated that 25% of known 
plasmids are conjugative, 25% are mobilizable and 50% are 
non–mobilizable (Smillie et al., 2010). Most of the very 
large plasmids are non–mobilizable, they carry many 
essential genes, and may be considered secondary 
chromosomes (Smillie et al., 2010). Horizontal transfer of 
plasmids, and other macromolecules, to other bacterial cells 
is mediated by bacterial type IV secretion systems (T4S) 
(Christie et al., 2005; Frost et al., 2005). During the transfer 
process a nucleoprotein particle that is covalently bound to 
the DNA to be transferred is formed (Christie et al., 2005). 
If this process is interrupted the plasmid may not be 
transferred.  
Plasmids may have the capacity to replicate in different 
genera, but in the Enterobacteriaceae plasmids with related 
replication elements cannot replicate in the same cell. This 
characteristic was used to classify this group of plasmids 
based on their compatibility/ incompatibility (Inc) groups 
(Couturier et al., 1988). Multiple replication elements can 
exist on the same plasmid or on different plasmids in the 
same cell if they are unrelated. Until 2005 determining the 
classification of a plasmid was done by the labor intensive 
method of Southern blot hybridization (Couturier et al., 
1988). In 2005, a PCR–based replicon typing method was 
developed that greatly simplified plasmid typing in 
Enterobacteriaceae (Carattoli et al., 2005). This technique 
has greatly facilitated knowledge in the epidemiology of 
Inc plasmid dissemination. Certain Inc types are now 
associated with multiple drug resistance and foodborne 
disease outbreaks (Lindsey et al., 2009). The IncA/C 
replicons are associated with extended–spectrum β–
lactamases (ESBLs) and Ampicillin C family (AmpC) of 
β–cephalosporinases. The AmpC β CMY–2 (blaCMY–2) is 
prevalent among Salmonella enterica serovars and 
Escherichia coli in the United States (Lindsey et al., 2009; 
Poole et al., 2009; Call et al., 2010). Salmonella enterica 
Newport MDR–AmpC, was first reported as an outbreak in 
the United States in 2002 (CDC, 2002) and has been 
recognized as an epidemic strain in humans and animals 
and has spread across the United States in the last decade 
(Cobbold et al., 2006).  
The development of on–farm management methods 
that would decrease the spread of antimicrobial resistance 
may be developed if one of two mechanisms of 
dissemination was determined to be the most prevalent: 1) 
horizontal transfer of resistance genes to other bacterial 
cells at the molecular level or, 2) clonal expansion of the 
population of MDR bacterial strains. It seems likely that 
both mechanisms occur simultaneously.   
Flavophospholipol has been shown to inhibit 
conjugation frequency in vitro (George and Fagerberg, 
1984; Poole et al., 2006). In vivo flavophospholipol may 
have inhibited conjugative transfer from the exogenous 
donor strains plasmids, but it did not prevent the recipient 
from acquiring naturally occurring plasmids (Poole et al., 
2006). This was evident by the presence of gentamicin 
resistance not present in the donor strain. It would be 
preferable to find nutritional supplements that could inhibit 
conjugative transfer that would be low in toxicity and are 
not antimicrobial in nature. 
The IncA/C plasmid has a number of different plasmid 
backbones (Fricke et al., 2009; Call et al., 2010). In some 
IncA/C plasmid backbones that are blaCMY–2 positive, a 
blaCMY–2–hyb repeat region has integrated in between traA 
and traC genes responsible for conjugative transfer (Fricke 
et al., 2009; Poole et al., 2009). In Salmonella  Newport 
isolated from cattle that carried only the blaCMY–2 positive 
IncA/C plasmid, the plasmid was  non–conjugative. In 
strains that carried blaCMY–2 negative IncA/C plasmids, the 
plasmids were conjugative. Strains possessing the blaCMY–2 
positive IncA/C plasmids, with certain co–resident 
plasmids, transferred the deficient IncA/C plasmids with 
the co–resident plasmid (Poole et al., 2009). This 
demonstrated that conjugative transfer negative strains of 
Salmonella  Newport with blaCMY–2  positive IncA/C 
plasmids were able to spread across the United States in 
epidemic fashion regardless of its inability to directly 
transfer its IncA/C plasmid (Poole et al., 2009). 
Other mobile genetic elements that may be located on 
plasmids include transposons and integrons (Stokes and 
Hall, 1989; Liebert et al., 1999). Transposons can excise 
themselves from a segment of DNA and integrate into 
another segment of DNA. This includes transfer to and 
from chromosomal and plasmid DNA. Transposons are 
characterized by repeats that flank an intervening section of 
DNA that contains a transposase, resolvase and 
antimicrobial resistance genes. The repeat segments may or 
may not be inverted (Liebert et al., 1999). 
Integrative Conjugative Elements (ICEs) and 
Integrative Mobilizable Elements (IMEs) are elements that 
integrate into the bacterial chromosome. For in–depth 
reviews on ICEs and IMEs see (Burrus and Waldor, 2004; 
Doublet et al., 2005). Recently it has been shown that many 
of the conjugative IncA/C MDR plasmids specifically 
mobilize the Salmonella Genomic Island 1 (SGI1) (Douard 
et al., 2010). SGI1 has previously been defined as an IME 
(Doublet et al., 2005). 
Independently mobile DNA elements called integrons 
are located on many transposons and may transfer to a 
plasmid or chromosomal location. Integrons encode a 
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acquisition of gene cassettes that may carry antimicrobial 
resistance genes (Hall and Collis, 1995). An integron also 
includes an (attI) site necessary for recombinant 
recognition. MDR Enterobacteriaceae has been highly 
associated with the presence of Class 1 integrons with 
multiple integron–associated resistance gene cassettes in 
the conserved segment (CS) (Martinez-Freijo et al., 1998; 
Leverstein-van Hall et al., 2002). Aeromonas hydrophia 
isolated from diarrheic swine was found to have a number 
of antimicrobial resistance genes including a macrolide 
inactivation gene cluster downstream of a Class 1 
integron. In contrast, Aeromonas hydrophia isolates from 
the White River in Indiana, in the United States possessed 
Class 1 integrons, but the CS segment did not carry 
integron–associated resistance gene cassettes or any other 
genes (Poole et al., 2006). This may have been due to a 
lack of antimicrobial selection pressure in the river. 
In addition to dissemination of mobile genetic 
elements between bacterial species or strains, clonal 
expansion of antimicrobial resistant isolates is a factor in 
the epidemic spread of some strains. Clonal expansion of 
resistant bacteria often occurs when clinical use of 
antimicrobials disrupts the ecological balance allowing 
strains exhibiting antimicrobial resistance phenotypes to 
multiply to a much higher population than would be 
observed in antimicrobial free environmental niche (Levy, 
1997). This may open an ecological niche, shifting the 
overall ecology. In some cases, the niche may return to its 
previous bacterial diversity once antimicrobials have been 
removed. Antimicrobial use may also select for MDR 
bacteria due to the presence of multiple resistance genes 
on the same mobile element. Global use of antimicrobials 
for the last several decades has resulted in the 
accumulation of multiple antimicrobial resistance traits 
within single bacterial strains (Glenn et al., 2012). 
 
Mechanisms of Resistance: Most antimicrobial drugs act 
on essential metabolic or structural processes of the 
bacterial cell, these include: inhibition of cell wall 
synthesis; nucleic acid replication and synthesis; protein 
synthesis or disruption of cell wall structure (McDermott 
et al., 2003). 
Resistance to antimicrobials fall into two broad 
categories: intrinsic or acquired. Intrinsic resistance refers 
to tolerance of an antimicrobial due to the natural 
physiology of that particular genus or species with regard 
to the chemical structure of the drug. In some cases this 
occurs if a bacterial genus or species does not possess the 
metabolic or structural target for inhibition (McDermott et 
al., 2003). For example, Gram–negative bacteria are 
intrinsically resistant to glycopeptides (e.g. vancomycin) 
and macrolides (e.g. tylosin) because these drugs are 
structurally too large to penetrate the outer membrane that 
exists among all Gram–negative bacteria. Alternatively, 
Enterococci are intrinsically resistant to cephalosporins 
due to insufficient binding affinity to penicillin binding 
proteins (PBPs) (Williamson et al., 1985). Leuconostoc, 
Pediococcus,  Enterococcus gallinarum and Lactobacilli 
are Gram–positive bacteria that possess an alternative 
pathway for cell wall construction and are resistant to 
glycopeptides. Intrinsic resistant may be displayed as low 
level resistance which is the case of E. gallinarum to 
vancomycin (Leclercq et al., 1992). The genetic 
determinants that confer intrinsic resistance are generally 
located on the bacterial chromosome, since they encode 
essential structural or biochemical functions for the 
species, and are not easily transferred horizontally or 
expressed in other bacterial strains. However, some of 
genetic determinants capable of expression have become 
translocated to mobile genetic elements, thus, increasing 
the spread of resistance. 
Acquired resistance is exemplified by two general 
mechanisms: 1) when a mutation has occurred in a gene, 
often located on the bacterial chromosome, or 2) when the 
bacterium acquires exogenous genes on mobile DNA 
elements as discussed above. 
Cross resistance occurs when one mechanism confers 
resistance to multiple antibiotics or classes of antibiotics. 
To understand this, and other mechanisms of resistance, it 
is necessary to understand the biochemical pathways that 
antimicrobials target. 
 
Modification of the Antimicrobial: Drug modification 
occurs when an enzyme catalyzes a structural change of 
the drug such that its mechanism of action is no longer 
effective for bacterial inhibition. Antibiotic classes that 
are inhibited by this mechanism include: β–lactams, 
aminoglycosides, chloramphenicol, streptogramins and 
macrolides (McDermott et al., 2003).  
β–lactam antimicrobials act by binding to cell wall 
synthesizing proteins PBPs which effectively inhibits cell 
growth. The most commonly encountered mechanism of 
resistance for β–lactam antibiotics in Gram–negative 
bacteria is hydrolysis of the β–lactam ring by β–lactamase 
enzymes (Rice and Bonomo, 2011). Newer β–lactam 
antimicrobials have been developed that possess an 
extended spectrum of activity and bacteria have developed 
resistance to these in the form of ESBLs and AmpC  β–
cephalosporinases. An extensive family of β–lactamases 
exist and have been previously described (Bradford, 2001; 
Bush and Jacoby, 2010; Pfeifer et al., 2010; Smet et al., 
2010). These enzymes have been frequently identified in 
the microbiota of food producing animals (Smet et al., 
2010). 
There are three mechanisms of aminoglycoside 
inactivation, these include drug modification by: 
acetylation, adenylylation and phosphorylation. Each 
mechanism is represented by a family of multiple 
enzymes (Shaw et al., 1993; Davies and Wright, 1997). 
Among these are ATP–dependent O–phosphorylation by 
phosphotransferases (APHs), ATP–dependent O–
adenylation by adenylytransferases or nucleotidyl 
transferases (ANTs) and acetyl CoA–dependent N–
acetylation by acetyltransferases (AACs). These enzymes 
are widespread and have been identified in most Gram–
negative and Gram–positive bacteria (Shaw et al., 1993; 
Murray and Shaw, 1997). 
Chloramphenicol acetyltransferases (CAT) enzymes 
are the most frequently observed mechanism of resistance 
to chloramphenicol identified among pathogens. CAT 
enzymes catalyze the acetyl–S–CoA–dependent 
acetylation of chloramphenicol. 
Macrolides and lincosamides are structurally distinct; 
however, they share a similar mechanism of action and 
spectrum of activity. Lincosamides do not possess the 
lactone ring that constitutes the macrolide class of Pak Vet J, 2013, 33(3): 266-271. 
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antimicrobials (Leclercq, 2002). Hydrolysis of the lactone 
ring of macrolides by esterases inhibits the antibiotic and 
was first observed in 1984 (Barthelemy et al., 1984). The 
E. coli ereB gene encodes erythromycin esterase II that 
hydrolyzes the lactone ring of erythromycin A and 
oleandomycin (Ounissi and Courvalin, 1985; Andremont 
et al., 1986). Resistance to macrolide antimicrobials, but 
not lincosamides or streptogramins could occur as the 
result of enzymatic phosphorylation of the drug (Noguchi 
et al., 1995; Noguchi et al., 2000). Macrolide 2’–
phosphotransferase (MPH) has been found in clinical E. 
coli isolates (Noguchi et al., 2000) and Aeromonas 
hydrophila a fish pathogen that can also cause hemolytic 
uremic syndrome (HUS) in humans (Poole et al., 2006). 
The macrolide inactivation observed in E. coli and A. 
hydrophila MPH exists as a gene cluster including mphA–
mrx–mphR and is located downstream of a class 1 
integron and is present on a TN21–like transposon. The 
presence of the esterases and phosphotransferases in 
Enterobacteriaceae has little significance because this 
family is intrinsically resistant to macrolide antimicrobials 
due to drug efflux transporters (Leclercq, 2002). 
However, this operon could, if expressed in Gram–
positives, confer a more clinically significant resistance to 
macrolides. Staphylococcus aureus, that produces mphC, 
does inactivate macrolide antimicrobials. Nucleotidy- 
ltransferases encoded by lnuA and lnuB  produced by 
Enterococcus faecium inactivates streptogramins. 
 
Modification of the Drug Target: Structural 
modification of the antimicrobial drug target may render 
the drug ineffective, particularly if binding of the drug to 
the target is necessary. The interaction between the target 
molecule and antimicrobial is very specific and small 
structural changes, induced by point mutations that 
encode a different amino acid, may affect the binding 
affinity of the antimicrobial to its target (McDermott et 
al., 2003; Giedraitiene et al., 2011). A post–translational 
modification of the target molecule by an enzyme may 
also reduce the efficacy of the drug. Antimicrobials that 
are inhibited by target modification include: β–lactams, 
aminoglycosides, macrolides, lincosamides, streptogramins, 
quinolones, rifampicin, trimethoprim, tetracyclines, and 
mupirocin (McDermott et al., 2003). 
As previously discussed, hydrolysis of the β–lactam 
ring of β–lactam antimicrobials is a common resistance 
mechanism among Gram–negative bacteria; for Gram–
positive bacteria, target modification is the most 
commonly encountered mechanism of resistance for β–
lactam antibiotics. Bacteria that produce PBPs that have a 
reduced binding affinity to β–lactam antibiotics display a 
resistant phenotype (Rice and Bonomo, 2011). In contrast, 
it has been long known that enterococci are intrinsically 
resistant to penicillin due to the production of low–affinity 
BPBs (Williamson et al., 1985). 
Aminoglycosides primarily act by binding to the 16S 
rRNA that recognizes the aminoacyl–tRNA; this action 
inhibits bacterial protein synthesis (Magnet and 
Blanchard, 2004). Target modification by ribosomal 
mutations or enzymatic modifications of ribosomal 
components inhibit the action of aminoglycosides (Davies 
and Wright, 1997). A number of Actinomycetes that 
produce aminoglycosides also produce 16S rRNA 
methylases that protect them from the inhibitory effects of 
the antibiotic (Magnet and Blanchard, 2004). Two rRNA 
methyltransferases (rmtA and rmtB) had primarily been 
identified only in aminoglycoside producing 
microorganisms until 2003 and 2004 (Magnet and 
Blanchard, 2004), when they were identified on plasmids–
borne transposons in human Gram–negative pathogens 
(Yokoyama et al., 2003; Doi et al., 2004). By 2010 seven 
16S rRNA methyltransferase genes had been identified: 
armA, rmtA, rmtB, rmtC, rmtD, rmtE and npmA. 
Cross–resistance to macrolides, lincosamides and 
streptogramins (MLS) occurs by methylation of the 
ribosomal target. There are a number of erythromycin 
ribosome methylase (erm) enzymes that confer macrolide 
resistance to Gram–positive bacteria, spirochetes and 
anaerobes (Leclercq, 2002). 
Tetracyclines inhibit bacterial protein synthesis by 
preventing the attachment of t–RNA to the ribosome 
(Chopra and Roberts, 2001). Tetracycline resistance due 
to target modification is mediated by ribosomal protection 
proteins (RPP) that represent a widely distributed class of 
resistance genes (Thaker et al., 2010). There are 11 type 
of RPPs found among Gram–positive and Gram–negative 
genera. Tet(O) and Tet(M) are the most prevalent and 
well–studied. The individual RPP genes include: tet(O), 
tet(M),  tet(S),  tet(W),  tet(32),  tet(32),  tet(36),  tetB(P), 
otr(A) and tet (Thaker et al., 2010).  
Fluoroquinolones are broad spectrum antibiotics that 
act by inhibiting bacterial DNA replication by binding to 
two essential enzymes, DNA topoisomerase IV consisting 
of two subunits of each ParC and ParE and DNA gyrase 
composed of two subunits of each GyrA and GyrB 
(Hopkins et al., 2005). Accumulation mutations in parC 
and parE and/or gyrA and gyrB genes, primarily in the 
quinolone resistance–determining regions, may confer 
resistance to fluoroquinolones by reducing the binding 
affinity of the drug (Rice and Bonomo, 2011). Multiple 
mutations in these chromosomal genes are generally 
required to confer clinically significant resistance. 
In Enterobacteriaceae, plasmid mediated quinolone 
resistance (PMQR) is encoded by the qnr gene and was 
first identified in an integron–like element (Stokes et al., 
1993). In E. coli, Qnr protects DNA gyrase from 
inhibition by ciprofloxacin; however, it does not protect 
topoisomerase IV (Hopkins et al., 2005). 
 
Decreased Access of Drug to Target: Decreased access 
to the intracellular drug target is primarily a consequence 
of active drug efflux. This involves the extrusion of 
noxious substances out of the cell resulting in sub ￿toxic 
intracellular concentrations of the antimicrobials. This 
process may be very broad or narrow in substrate 
specificity depending on the type of efflux pump. Broad 
spectrum activity includes the expulsion of dyes and other 
inhibitory compounds (Nikaido and Pages, 2012). For this 
reason, expression of efflux proteins often confers 
resistance to multiple drugs simultaneously. Drug efflux is 
a highly prevalent mechanism of resistance among 
bacteria and there are primarily five types. These include: 
1) the major facilitator superfamily (MFS); 2) the small 
multidrug resistance family (SMR); 3) the resistance 
nodulation cell division family (RND); 4) the ATP 
binding cassette superfamily (ABC) and 5) the multidrug Pak Vet J, 2013, 33(3): 266-271. 
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and toxic compound extrusion family (MATE). In some 
cases multiple types of efflux proteins are present in one 
bacterial strain resulting in high–level resistance when 
neither protein alone confers resistance (Rice and 
Bonomo, 2011). Efflux may also enhance other 
mechanisms of resistance leading to clinically relevant 
resistance (Nikaido and Pages, 2012). Efflux pumps are 
usually encoded chromosomally and gene expression is 
activated by environmental signals or by mutations in 
regulatory genes that control expression (Levy, 2002). 
Efflux is active against all clinically relevant antimicrobial 
classes (Nikaido and Pages, 2012). 
 
Alternative Metabolic Pathway: Some bacteria possess 
or acquire a different metabolic pathway that by–passes 
the pathway the antimicrobial inhibits. In enterococci the 
peptidoglycan component of the cell wall is formed when 
two molecules of D–Ala–D–Ala are added to UDP–N–
acetylmuramyl–tripeptide to form the UDP–N–
acetylmuramyl–pentapeptide. This is subsequently 
incorporated into the nascent peptidoglycan providing the 
structure for formation of cross–bridges in the 
peptidoglycan layer (Cetinkaya, et al., 2000). 
Glycopeptide antibiotics inhibit cell wall synthesis in 
Gram–positive by binding to the D–Ala–D–Ala precursor, 
thus, blocking their addition to the nascent peptidoglycan 
chain (Cetinkaya et al., 2000). An example of low level 
intrinsic vancomycin resistance, VanC resistance, is 
exhibited in motile Enterococcus casseliflavus, E. 
gallinarum and E. flavescens. This is due to the ability to 
substitute D–Ala–D–Ala with D–Ala–D–Ser at the 
carboxyl terminus of the peptidoglycan precursor 
analogues this in turn lowers the affinity for vancomycin 
(Arthur et al., 1996). These species remain susceptible to 
teicoplanin (Arthur et al., 1996). 
 
Conclusion:  In Agriculture there is a need to employ 
management strategies that would minimize the use of 
antimicrobials from farm to fork. Eliminating 
antimicrobial use in agriculture globally is unlikely. 
Dissemination of MDR commensal and pathogenic 
bacteria worldwide is continually reducing the efficacy of 
available antibiotics. Very few new antibiotics are under 
production, and for the most part, new antibiotics in the 
pipeline are derivatives of currently available drugs. It is 
therefore likely that cross–resistance will render the new 
drugs less effective. New drugs that target new 
mechanisms of bacterial cell metabolism are necessary. 
The antibiotic resistome may provide novel targets for 
new antimicrobials. One such antimicrobial peptide has 
recently been discovered by examining the Panda genome 
(Yan et al., 2012). A cathelicidin–like peptide derived 
from mining the Panda genome was synthesized and 
found to possess broad spectrum activity against Gram–
negative and Gram–positive bacteria as well as fungi 
(Alexander et al., 2011). 
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